Business Daily from THE HINDU group of publications
Tuesday, Aug 12, 2008
ePaper | Mobile/PDA Version | Audio
News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

 Corporate - Standards & Benchmarks
Industry & Economy - Pharmaceuticals
Aurobindo anti-infective injection

Hyderabad, Aug. 11

Aurobindo Pharma Ltd has received final approval from the US Food and Drug Administration (US FDA) for cefazolin injection in 500 mg/vial and one gm/vial. The injection is under anti-infective segment and the generic equivalent to the drug Cefazolin listed in the Abrxis Pharmaceutical Products' Reference. This is the third product approval for the sterile injectable formulation line of the Hyderabad-based company's Unit VI-B, according to release. - Our Bureau

More Stories on : Standards & Benchmarks | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Venus launches ‘Tobracef’

Buyback proposals lift HEG stock 11%
Sagar Cements allots 6.67% stake to Parficim
ECB rate spreads may be revised
Hyderabad metro project to be completed in 5 1/2 years
BHEL bags EEPC top export award
HAL plans electronics facility at Kinfra park
KEC International setting up 400 telecom towers in rural areas
Gujarat NRE Minerals to raise $100 m
Naiknavare hands over 237 flats under Bharat Pattern project
HUL, Apollo to launch health awareness programme
Aurobindo anti-infective injection
L&T expects defence biz to grow with change in procurement norms
Honda launches Civic Sport at Rs 12.36 lakh




eWorld
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line